zofenopril has been researched along with Heart Disease, Ischemic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosio, G; Borghi, C; Mancia, G; Van De Borne, P | 1 |
| Dralova, OV; Ermolaeva, AS; Maksimov, ML | 1 |
| Frascarelli, S; Ghelardoni, S; Ronca-Testoni, S; Zucchi, R | 1 |
| Buikema, H | 1 |
| Ambrosioni, E | 1 |
| Antonaccio, MJ; Dzwonczyk, S; Grover, GJ; Normandin, D; Sargent, CA; Sleph, PG; Smith, MA | 1 |
| Boraso, A; Cargnoni, A; Ceconi, C; Curello, S; Ferrari, R; Visioli, O | 1 |
3 review(s) available for zofenopril and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Modem inhibitor angiotensin-converting enzyme zofenopril in the primary and secondary prevention of cardiovascular disease].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Humans; Hypertension; Myocardial Ischemia; Outcome Assessment, Health Care; Renin-Angiotensin System | 2014 |
Use of the ACE inhibitor zofenopril in the treatment of ischemic heart disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; History, 19th Century; History, 20th Century; Humans; Myocardial Infarction; Myocardial Ischemia | 2006 |
Defining the role of zofenopril in the management of hypertension and ischemic heart disorders.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Drug Administration Schedule; Humans; Hypertension; Myocardial Ischemia; Treatment Outcome | 2007 |
4 other study(ies) available for zofenopril and Heart Disease, Ischemic
| Article | Year |
|---|---|
Zofenopril: Blood pressure control and cardio-protection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diuretics; Humans; Hypertension; Myocardial Ischemia | 2022 |
Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Rate; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar | 2004 |
Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Vessels; Male; Myocardial Contraction; Myocardial Ischemia; Potassium Channels; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Stereoisomerism | 1993 |
Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Captopril; Creatine Kinase; Hemodynamics; In Vitro Techniques; Lactates; Male; Mitochondria, Heart; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Norepinephrine; Oxidation-Reduction; Phosphocreatine; Rabbits | 1992 |